Bio-Thera Solutions

Quick facts

Marketed products

• QLETLI · Other

Phase 3 pipeline

• Actemra(EU-licensed) · Immunology
  Actemra (tocilizumab) is an IL-6 receptor antagonist that blocks interleukin-6 signaling to reduce inflammatory responses.
• BAT1406 · Oncology
  BAT1406 is a bispecific antibody that simultaneously engages PD-1 on immune cells and TGF-β in the tumor microenvironment to enhance anti-tumor immunity.
• BAT1706 · Oncology
  BAT1706 is a bispecific antibody that simultaneously engages PD-1 on T cells and TGF-β in the tumor microenvironment to enhance anti-tumor immunity.
• BAT1806 · Oncology
  BAT1806 is a bispecific antibody that simultaneously engages PD-1 on immune cells and TGF-β in the tumor microenvironment to enhance anti-tumor immunity.
• BAT2206 · Oncology
  BAT2206 is a bispecific antibody that simultaneously engages two immune checkpoints to enhance anti-tumor T-cell responses.
• BAT2306 · Oncology
  BAT2306 is a bispecific antibody that simultaneously engages two immune checkpoints to enhance anti-tumor T cell responses.
• BAT2506 injection · Oncology
  BAT2506 is a bispecific antibody that simultaneously engages two immune checkpoints to enhance anti-tumor T cell responses.
• BAT3306 · Oncology
  BAT3306 is a monoclonal antibody targeting PD-1.
• BAT5906 injection · Oncology
  BAT5906 is a bispecific antibody that simultaneously engages two immune checkpoints to enhance anti-tumor T cell responses.
• BAT8001 for injection · Oncology
  BAT8001 is a bispecific antibody that simultaneously engages tumor-associated antigens and immune effector cells to enhance anti-tumor immunity.
• EU Avastin® · Oncology
  Avastin (bevacizumab) is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF) to inhibit tumor blood vessel formation and slow cancer growth.
• EU Simponi · Immunology
  Simponi is a TNF-alpha inhibitor that blocks tumor necrosis factor signaling to reduce inflammation in autoimmune diseases.
• Paclitaxel for Injection · Oncology
  Paclitaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.
• Stelara (EU-sourced) · Immunology / Gastroenterology / Dermatology
  Stelara is a human monoclonal antibody that blocks the IL-12 and IL-23 cytokines to suppress immune-mediated inflammation.
• US-Keytruda® · Oncology
  US-Keytruda is a PD-1 inhibitor that blocks the interaction between PD-1 on T cells and PD-L1/PD-L2 on tumor cells, thereby restoring anti-tumor immune responses.

Phase 2 pipeline

• BAT4406F Injection · Oncology
  BAT4406F Injection is a monoclonal antibody targeting CD47.

Phase 1 pipeline

• BAT1006
• BAT2022
• BAT8001
• Monoclonal antibody BAT6026

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Bio-Thera Solutions portfolio CI brief
• Bio-Thera Solutions pipeline updates RSS

Frequently asked questions about Bio-Thera Solutions

Related

• QLETLI · Other
• Sector hub: All tracked pharma companies